Modulation of iron transport proteins in human colorectal carcinogenesis
- M J Brookes1,
- S Hughes1,
- F E Turner2,
- G Reynolds1,
- N Sharma1,
- T Ismail1,
- G Berx3,
- A T McKie4,
- N Hotchin2,
- G J Anderson5,
- T Iqbal6,*,
- C Tselepis1,*
- 1Cancer Research UK Institute for Cancer Studies, University of Birmingham, UK
- 2School of Biosciences, University of Birmingham, UK
- 3Department for Molecular Biomedical Research, VIB-Ghent University, Belgium
- 4Division of Nutritional Sciences, Kings College London, UK
- 5Iron Metabolism Laboratory, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, Queensland, Australia
- 6Gastroenterology Unit, Walsgrave Hospital, UK
- Correspondence to:
Dr C Tselepis
Cancer Research UK Institute for Cancer Studies, University of Birmingham, Vincent Drive, Birmingham B15 2TH, UK;
- Accepted 4 April 2006
- Revised 15 March 2006
- Published Online First 26 April 2006
Background and aims: Total body iron and high dietary iron intake are risk factors for colorectal cancer. To date there is no comprehensive characterisation of iron transport proteins in progression to colorectal carcinoma. In this study, we examined expression of iron import (duodenal cytochrome b (DCYTB), divalent metal transporter 1 (DMT1), and transferrin receptor 1 (TfR1)) and export (hephaestin (HEPH) and ferroportin (FPN)) proteins in colorectal carcinoma.
Methods: Perl’s staining was used to examine colonocyte iron content. Real time polymerase chain reaction (PCR) and western blotting were used to examine mRNA and protein levels of the molecules of interest in 11 human colorectal cancers. Semiquantitative immunohistochemistry was used to verify protein levels and information on cellular localisation. The effect of iron loading on E-cadherin expression in SW480 and Caco-2 cell lines was examined by promoter assays, real time PCR and western blotting.
Results: Perl’s staining showed increased iron in colorectal cancers, and there was a corresponding overexpression of components of the intracellular iron import machinery (DCYTB, DMT1, and TfR1). The iron exporter FPN was also overexpressed, but its intracellular location, combined with reduced HEPH levels, suggests reduced iron efflux in the majority of colorectal cancers examined. Loss of HEPH and FPN expression was associated with more advanced disease. Iron loading Caco-2 and SW480 cells caused cellular proliferation and E-cadherin repression.
Conclusions: Progression to colorectal cancer is associated with increased expression in iron import proteins and a block in iron export due to decreased expression and aberrant localisation of HEPH and FPN, respectively. This results in increased intracellular iron which may induce proliferation and repress cell adhesion.
- CRC, colorectal cancer
- DCYTB, duodenal cytochrome b
- DMT1, divalent metal transporter 1
- TfR1, transferrin receptor 1
- HEPH, hephaestin
- FPN, ferroportin
- PCR, polymerase chain reaction
- CK, cytokeratin
- PBS, phosphate buffered saline
- DAB diaminobenzidine,
- LGD, low grade dysplastic adenomas, HGD, high grade dysplastic adenomas
↵* C Tselepis and T Iqbal contributed equally to this work.
Published online first 26 April 2006
Grant support was received from the City Hospital Trust fund and the University of Birmingham Scientific project grant
Conflict of interest: None declared.